{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:42Z","timestamp":1786115082322,"version":"build-2736575974"},"reference-count":218,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189660","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:14:36Z","timestamp":1783700076000},"page":"189660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping epigenetic alterations across brain tumor hallmarks"],"prefix":"10.1016","volume":"1881","author":[{"given":"Celeste","family":"Antonacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Abballe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Di Giannatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189660_bb0005","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1097\/JS9.0000000000004417","article-title":"Global patterns and trends in brain and central nervous system tumor incidence by histological subtype in 185 countries in 2022: a population-based study","volume":"112","author":"Lei","year":"2026","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.bbcan.2026.189660_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/neuonc\/nov249","article-title":"Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010","volume":"18","author":"Rouse","year":"2016","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0015","first-page":"18","article-title":"Late effects of cancer treatment: consequences for long-term brain cancer survivors","volume":"8","author":"Alemany","year":"2021","journal-title":"Neurooncol. Pract."},{"key":"10.1016\/j.bbcan.2026.189660_bb0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0025","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12311-017-0899-9","article-title":"Epigenetic drivers in pediatric Medulloblastoma","volume":"17","author":"Roussel","year":"2018","journal-title":"Cerebellum"},{"key":"10.1016\/j.bbcan.2026.189660_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-020-03562-0","article-title":"Weighing ependymoma as an epigenetic disease","volume":"150","author":"Stuckert","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0040","article-title":"Development and epigenetic regulation of atypical teratoid\/rhabdoid tumors in the context of cell-of-origin and halted cell differentiation","volume":"6","author":"Huhtala","year":"2024","journal-title":"Neuro-oncol. Adv."},{"key":"10.1016\/j.bbcan.2026.189660_bb0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189660_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/cns.14.50","article-title":"Assessing MGMT methylation status and its current impact on treatment in glioblastoma","volume":"4","author":"Berghoff","year":"2015","journal-title":"CNS Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0055","first-page":"1954","article-title":"Epigenetic mechanisms and the hallmarks of cancer: an intimate affair","volume":"10","author":"Darwiche","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0060","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10616-018-0260-2","article-title":"Molecular characterization of Wnt pathway and function of \u03b2-catenin overexpression in medulloblastoma cell lines","volume":"70","author":"Geron","year":"2018","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0065","article-title":"Sonic hedgehog signaling in cerebellar development and cancer","volume":"10","author":"Wang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0070","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3390\/cancers13133210","article-title":"Epigenetic deregulation of apoptosis in cancers","volume":"13","author":"Ozyerli-Goknar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189660_bb0075","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/s41388-025-03315-1","article-title":"The epigenetic landscape of brain metastasis","volume":"44","author":"Powell","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1116805","article-title":"Epigenetic reprogramming in cancer: from diagnosis to treatment","volume":"11","author":"Costa","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0085","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1007\/s12672-025-04085-8","article-title":"Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery","volume":"16","author":"Ng","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189660_bb0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.bbcan.2026.189660_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.canlet.2012.04.008","article-title":"Epigenetics in human gliomas","volume":"342","author":"Kreth","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189660_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2026.189660_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1152\/physrev.00012.2010","article-title":"Epigenetic regulation of gene expression in physiological and pathological brain processes","volume":"91","author":"Gr\u00e4ff","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbcan.2026.189660_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104940","article-title":"Understanding the epigenetic landscape and cellular architecture of childhood brain tumors","volume":"144","author":"Alencastro Veiga Cruzeiro","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbcan.2026.189660_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbi.2025.102787","article-title":"DNA methylation dynamics: patterns, regulation, and function","volume":"88","author":"Gwee","year":"2025","journal-title":"Curr. Opin. Plant Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/ctd2.279","article-title":"Role of DNA methylation in cancer development and its clinical applications","volume":"4","author":"Sonar","year":"2024","journal-title":"Clin. Transl. Dis."},{"key":"10.1016\/j.bbcan.2026.189660_bb0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yexmp.2016.02.002","article-title":"Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas","volume":"100","author":"Purkait","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-021-00857-0","article-title":"Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications","volume":"7","author":"Lopez-Bertoni","year":"2022","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.bbcan.2026.189660_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5114\/fn.2016.60365","article-title":"High expression of DNA methyltransferases in primary human medulloblastoma","volume":"2","author":"P\u00f3cza","year":"2016","journal-title":"fn"},{"key":"10.1016\/j.bbcan.2026.189660_bb0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13059-021-02352-9","article-title":"Ten-eleven translocation protein 1 modulates medulloblastoma progression","volume":"22","author":"Kim","year":"2021","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40478-024-01831-x","article-title":"Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma","volume":"12","author":"Tsiami","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbcan.2026.189660_bb0155","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.21037\/tcr-23-1943","article-title":"DNMT3A promotes glioma growth and malignancy via TNF-\u03b1\/NF-\u03baB signaling pathway","volume":"13","author":"Su","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11060-020-03546-0","article-title":"Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities","volume":"150","author":"Sun","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-15-8104-5_1","article-title":"Overview of histone modification","volume":"1283","author":"Zhang","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","article-title":"Epigenetic regulators in cancer therapy and progression","volume":"9","author":"Marei","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0180","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0185","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/cr.2011.42","article-title":"Readers of histone modifications","volume":"21","author":"Yun","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00401-012-1070-9","article-title":"Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma","volume":"125","author":"Dubuc","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0195","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189660_bb0200","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA Hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0205","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M represses p16 to accelerate Gliomagenesis in a murine model of DIPG","volume":"15","author":"Cordero","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0210","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-019-09981-6","article-title":"PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism","volume":"10","author":"Jain","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189660_bb0215","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1255104","article-title":"Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling","volume":"345","author":"Herz","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189660_bb0220","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/bpa.12042","article-title":"Evaluation of H istone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas","volume":"23","author":"Venneti","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0225","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ccell.2019.04.004","article-title":"Pervasive H3K27 acetylation leads to ERV expression and a therapeutic vulnerability in H3K27M gliomas","volume":"35","author":"Krug","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.3746","article-title":"SMARCB1-mediated SWI\/SNF complex function is essential for enhancer regulation","volume":"49","author":"Wang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2026.189660_bb0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrm.2017.26","article-title":"Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes","volume":"18","author":"Clapier","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114200","article-title":"The mechanisms of action of chromatin remodelers and implications in development and disease","volume":"180","author":"Sahu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0245","doi-asserted-by":"crossref","first-page":"12815","DOI":"10.3390\/ijms232112815","article-title":"Targeting chromatin-remodeling factors in cancer cells: promising molecules in cancer therapy","volume":"23","author":"Zhang","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.bbcan.2026.189660_bb0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189660_bb0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2013.07.030","article-title":"Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics","volume":"264","author":"Batora","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbcan.2026.189660_bb0260","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0265","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ccell.2016.02.009","article-title":"Genome-wide profiles of extra-cranial malignant Rhabdoid tumors reveal heterogeneity and dysregulated developmental pathways","volume":"29","author":"Chun","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-014-1323-x","article-title":"SMARCA4-mutated atypical teratoid\/rhabdoid tumors are associated with inherited germline alterations and poor prognosis","volume":"128","author":"Hasselblatt","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0275","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41419-022-05439-8","article-title":"SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189660_bb0280","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature11213","article-title":"Novel mutations target distinct subgroups of medulloblastoma","volume":"488","author":"Robinson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189660_bb0285","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.celrep.2017.11.021","article-title":"Convergence of BMI1 and CHD7 on ERK signaling in medulloblastoma","volume":"21","author":"Badodi","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb0290","article-title":"miRNAs: biosynthesis, mechanism of action, and applications in biological systems","volume":"39","author":"Liu","year":"2025","journal-title":"Gene Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111528","article-title":"MicroRNA: a signature for cancer progression","volume":"138","author":"Hussen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2026.189660_bb0300","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications","volume":"44","author":"Di Martino","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/neuonc\/not215","article-title":"High-throughput microRNA profiling of pediatric high-grade gliomas","volume":"16","author":"Miele","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0310","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ijc.23948","article-title":"MicroRNA profiling in human medulloblastoma","volume":"124","author":"Ferretti","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0315","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1158\/0008-5472.CAN-08-4710","article-title":"The miR-17\/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors","volume":"69","author":"Northcott","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0320","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1158\/0008-5472.CAN-13-0927","article-title":"Silencing of the miR-17\u223c92 cluster family inhibits medulloblastoma progression","volume":"73","author":"Murphy","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104550","article-title":"miRNA signature in glioblastoma: potential biomarkers and therapeutic targets","volume":"117","author":"Rezaei","year":"2020","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0330","first-page":"1379","article-title":"MicroRNA expression in pediatric intracranial ependymomas and their potential value for tumor grading","volume":"17","author":"Cipro","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2026.189660_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025114","article-title":"Identification of microRNAs as potential prognostic markers in ependymoma","volume":"6","author":"Costa","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189660_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158464","article-title":"Altered MicroRNA expression is associated with tumor grade, molecular background and outcome in childhood infratentorial ependymoma","volume":"11","author":"Zakrzewska","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2026.189660_bb0345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0350","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/neuonc\/nos140","article-title":"PTEN promoter methylation and activation of the PI3K\/Akt\/mTOR pathway in pediatric gliomas and influence on clinical outcome","volume":"14","author":"Mueller","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0355","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1215\/15228517-2007-003","article-title":"Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma","volume":"9","author":"Wiencke","year":"2007","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0360","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-003-0748-4","article-title":"PTEN methylation and expression in glioblastomas","volume":"106","author":"Baeza","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0365","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/sj.onc.1207407","article-title":"Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas","volume":"23","author":"Hesson","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0370","first-page":"5906","article-title":"Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development","volume":"62","author":"Lusher","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0375","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.onc.1209137","article-title":"Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid\/rhabdoid tumors (AT\/RT) of childhood","volume":"25","author":"M\u00fchlisch","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0380","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2004.11.044","article-title":"Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma","volume":"227","author":"Hamilton","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189660_bb0385","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1593\/neo.91122","article-title":"Genetic and epigenetic inactivation of Kruppel-like factor 4 in Medulloblastoma","volume":"12","author":"Nakahara","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2026.189660_bb0390","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/neuonc\/nor036","article-title":"The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence","volume":"13","author":"Lambiv","year":"2011","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0395","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1158\/0008-5472.CAN-09-3218","article-title":"Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells","volume":"70","author":"Waha","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0400","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13353-015-0312-7","article-title":"Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival","volume":"57","author":"Majchrzak-Celi\u0144ska","year":"2016","journal-title":"J. Appl. Genet."},{"key":"10.1016\/j.bbcan.2026.189660_bb0405","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jnen\/62.11.1192","article-title":"Epigenetic silencing of the HIC-1 gene in human medulloblastomas","volume":"62","author":"Waha","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0410","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11060-020-03591-9","article-title":"Medulloblastoma epigenetics and the path to clinical innovation","volume":"150","author":"Haltom","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0415","doi-asserted-by":"crossref","DOI":"10.18632\/aging.205750","article-title":"Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1","author":"Ren","year":"2024","journal-title":"Aging"},{"key":"10.1016\/j.bbcan.2026.189660_bb0420","doi-asserted-by":"crossref","first-page":"44398","DOI":"10.18632\/oncotarget.17897","article-title":"Methylation regulates HEY1 expression in glioblastoma","volume":"8","author":"Tsung","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb0425","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/iub.2463","article-title":"Epigenetic targeting of SLC30A3 by HDAC1 is related to the malignant phenotype of glioblastoma","volume":"73","author":"Zhang","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbcan.2026.189660_bb0430","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1084\/jem.20190196","article-title":"Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma","volume":"216","author":"Mack","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0435","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/bjc.2013.764","article-title":"Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma","volume":"110","author":"Fiaschetti","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0440","doi-asserted-by":"crossref","first-page":"78813","DOI":"10.18632\/oncotarget.12385","article-title":"miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3","volume":"7","author":"Shan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb0445","doi-asserted-by":"crossref","first-page":"19723","DOI":"10.18632\/oncotarget.7736","article-title":"Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas","volume":"7","author":"Liang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb0450","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ejca.2010.11.026","article-title":"miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion","volume":"47","author":"Fowler","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0455","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1947601912448068","article-title":"Current progress on understanding MicroRNAs in glioblastoma multiforme","volume":"3","author":"Karsy","year":"2012","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2017.02.120","article-title":"miR-124 suppresses glioblastoma growth and potentiates chemosensitivity by inhibiting AURKA","volume":"486","author":"Qiao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189660_bb0465","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00109-008-0403-6","article-title":"MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a","volume":"87","author":"Zhang","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbcan.2026.189660_bb0470","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/onc.2011.380","article-title":"Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases","volume":"31","author":"Papagiannakopoulos","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0475","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature16490","article-title":"Insulator dysfunction and oncogene activation in IDH mutant gliomas","volume":"529","author":"Flavahan","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189660_bb0480","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1535-6108(02)00102-2","article-title":"The RB and p53 pathways in cancer","volume":"2","author":"Sherr","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0485","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1101\/gad.1256504","article-title":"Living with or without cyclins and cyclin-dependent kinases","volume":"18","author":"Sherr","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2026.189660_bb0490","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/labinvest.3780213","article-title":"Promoter Hypermethylation of the RB1 gene in glioblastomas","volume":"81","author":"Nakamura","year":"2001","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbcan.2026.189660_bb0495","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.bjc.6600737","article-title":"CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours","volume":"88","author":"Gonzalez-Gomez","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0500","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3892\/ijo.22.3.601","article-title":"Promoter hypermethylation of multiple genes in astrocytic gliomas","volume":"22","author":"Gonzalez-Gomez","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0505","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149232","article-title":"Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells","volume":"6","author":"Lo Cascio","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2026.189660_bb0510","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41388-019-1036-7","article-title":"EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1\/p53 tumor suppressor pathway","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0515","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1750-3639.2006.00030.x","article-title":"Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression","volume":"17","author":"Watanabe","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0520","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3346\/jkms.2000.15.5.555","article-title":"5\u2019 CpG island methylation of p16 is associated with absence of p16 expression in glioblastomas","volume":"15","author":"Park","year":"2000","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.bbcan.2026.189660_bb0525","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1101\/gr.164707.113","article-title":"Recurrent epimutations activate gene body promoters in primary glioblastoma","volume":"24","author":"Nagarajan","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0530","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s13277-013-1200-6","article-title":"The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma","volume":"35","author":"Tivnan","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/neuonc\/nos281","article-title":"Expression of miR-124 inhibits growth of medulloblastoma cells","volume":"15","author":"Silber","year":"2013","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0540","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/1878-0261.12800","article-title":"Downregulation of miR-326 and its host gene \u03b2-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growth","volume":"15","author":"Miele","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0545","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12017-021-08684-w","article-title":"Prognostic value of miR-137 in children with Medulloblastoma and its regulatory effect on tumor progression","volume":"24","author":"Ji","year":"2022","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0550","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/ijmm.2017.2881","article-title":"DNA methylation-mediated caspase-8 downregulation is associated with anti-apoptotic activity and human malignant glioma grade","volume":"39","author":"Teng","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0555","doi-asserted-by":"crossref","DOI":"10.3892\/or.12.3.663","article-title":"Deletion and aberrant CpG island methylation of caspase 8 gene in medulloblastoma","author":"Gonzalez-Gomez","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb0560","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1158\/0008-5472.CAN-05-4552","article-title":"Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0565","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00401-005-1065-x","article-title":"Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas","volume":"110","author":"Nakamura","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0570","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/nan.12532","article-title":"MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy","volume":"45","author":"Krell","year":"2019","journal-title":"Neuropathol. Appl. Neurobio."},{"key":"10.1016\/j.bbcan.2026.189660_bb0575","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1038\/onc.2017.182","article-title":"Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis","volume":"36","author":"Tian","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0580","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40164-025-00597-9","article-title":"Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics","volume":"14","author":"Shou","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0585","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1470-2045(13)70110-4","article-title":"Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study","volume":"14","author":"Castelo-Branco","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0590","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12935-023-03130-2","article-title":"Cancer stem cells and their niche in cancer progression and therapy","volume":"23","author":"Liu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2026.189660_bb0595","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/or.2013.2456","article-title":"OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas","volume":"30","author":"Shi","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb0600","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/cr.2008.270","article-title":"Promoter hypomethylation regulates CD133 expression in human gliomas","volume":"18","author":"Tabu","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0605","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11010-014-2077-4","article-title":"Histone methyltransferase G9a and H3K9 dimethylation inhibit the self-renewal of glioma cancer stem cells","volume":"394","author":"Tao","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2026.189660_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107782","article-title":"NeuroD1 dictates tumor cell differentiation in medulloblastoma","volume":"31","author":"Cheng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb0615","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2007.12.005","article-title":"Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells","volume":"13","author":"Lee","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0620","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"key":"10.1016\/j.bbcan.2026.189660_bb0625","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.7314\/APJCP.2015.16.14.6129","article-title":"Epigenetic regulation of miR-129-2 leads to overexpression of PDGFRa and FoxP1 in glioma cells","volume":"16","author":"Tian","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.bbcan.2026.189660_bb0630","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1158\/0008-5472.CAN-10-2412","article-title":"The myc-miR-17\u223c92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors","volume":"70","author":"Dews","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0635","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3892\/mmr.2015.4537","article-title":"MicroRNA-566 modulates vascular endothelial growth factor by targeting Von Hippel-Landau in human glioblastoma in vitro and in vivo","volume":"13","author":"Xiao","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb0640","doi-asserted-by":"crossref","first-page":"710","DOI":"10.18632\/oncotarget.205","article-title":"miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis","volume":"1","author":"Smits","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb0645","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1158\/0008-5472.CAN-11-1157","article-title":"Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1","volume":"71","author":"Zhu","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0650","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2017.3320","article-title":"Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (review)","author":"\u0160kovierov\u00ef\u00bf\u00bd","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0655","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12967-025-06447-w","article-title":"Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease","volume":"23","author":"Khalili-Tanha","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0660","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/CEJ.0000000000000824","article-title":"CDH1 hypermethylation: a potential molecular pathway for invasiveness in glioblastoma","volume":"33","author":"Belut","year":"2024","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.bbcan.2026.189660_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174177","article-title":"EZH2 regulates the malignancy of human glioblastoma cells via modulation of twist mRNA stability","volume":"904","author":"Zhai","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0670","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","article-title":"Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas","volume":"20","author":"Barski","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0675","first-page":"3010","article-title":"MMP2 is associated with glioma malignancy and patient outcome","volume":"11","author":"Sincevi\u010di\u016bt\u0117","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0680","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720933241","article-title":"DNA methylation-based diagnostic and prognostic biomarkers for glioblastoma","volume":"29","author":"Tang","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbcan.2026.189660_bb0685","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41556-023-01093-0","article-title":"A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis","volume":"25","author":"Zou","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0690","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/carcin\/bgy022","article-title":"MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS","volume":"39","author":"Wang","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2026.189660_bb0695","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/MCB.00479-08","article-title":"MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators","volume":"28","author":"Gabriely","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0700","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0705","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","article-title":"Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential","volume":"55","author":"Xu","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0710","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.18632\/oncotarget.1159","article-title":"Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers","volume":"5","author":"Desai","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb0715","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jgg.2017.05.007","article-title":"A glycolysis-based ten-gene signature correlates with the clinical outcome, molecular subtype and IDH1 mutation in glioblastoma","volume":"44","author":"Chen","year":"2017","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.bbcan.2026.189660_bb0720","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41388-018-0423-9","article-title":"Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1\u03b1 stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment","volume":"38","author":"Feng","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0725","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40478-024-01750-x","article-title":"DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma","volume":"12","author":"Harachi","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbcan.2026.189660_bb0730","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.humpath.2009.02.003","article-title":"miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1","volume":"40","author":"Li","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0735","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13046-022-02305-5","article-title":"miR-3189-targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation","volume":"41","author":"Kwak","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0740","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.106005","article-title":"Epigenetic regulation of immune cells in central nervous system: from steady state to pathology","volume":"188","author":"Zhao","year":"2025","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbcan.2026.189660_bb0750","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41392-022-01093-w","article-title":"STING cg16983159 methylation: a key factor for glioblastoma immunosuppression","volume":"7","author":"Qiu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189660_bb0755","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41419-023-05878-x","article-title":"Epigenetically modified AP-2\u03b1 by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression","volume":"14","author":"Long","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189660_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/cells14181458","article-title":"Tumor-associated macrophages in glioblastoma: mechanisms of tumor progression and therapeutic strategies","volume":"14","author":"Chen","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189660_bb0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216265","article-title":"CDYL knockdown reduces glioma development through an antitumor immune response in the tumor microenvironment","volume":"567","author":"Kong","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189660_bb0770","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/neuonc\/noab292","article-title":"ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma","volume":"24","author":"Hu","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0775","doi-asserted-by":"crossref","first-page":"967","DOI":"10.18632\/oncotarget.27955","article-title":"Genome wide DNA methylation landscape reveals glioblastoma\u2019s influence on epigenetic changes in tumor infiltrating CD4+ T cells","volume":"12","author":"Bam","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb0780","doi-asserted-by":"crossref","first-page":"B028","DOI":"10.1158\/1538-7445.PEDIATRIC25-B028","article-title":"Abstract B028: MicroRNA-mediated reconstruction of the tumor microenvironment: enhancing CAR T-cell therapy for diffuse intrinsic pontine glioma","volume":"85","author":"Coleman","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0785","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0790","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","article-title":"The basis of oncoimmunology","volume":"164","author":"Palucka","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0795","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13046-019-1132-0","article-title":"The miR155HG\/miR-185\/ANXA2 loop contributes to glioblastoma growth and progression","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0800","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.molcel.2013.11.009","article-title":"Epigenetic regulation of the miR142-3p\/interleukin-6 circuit in glioblastoma","volume":"52","author":"Chiou","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0805","article-title":"MicroRNA-93 acts as an \u2018anti-inflammatory tumor suppressor\u2019 in glioblastoma","volume":"2","author":"H\u00fcbner","year":"2020","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.bbcan.2026.189660_bb0810","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194818","article-title":"Beyond the double-strand breaks: the role of DNA repair proteins in cancer stem-cell regulation","volume":"13","author":"Nathansen","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189660_bb0815","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10689-013-9607-1","article-title":"The prognostic value of MGMT promoter methylation in glioblastoma multiforme: a meta-analysis","volume":"12","author":"Zhang","year":"2013","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0820","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11060-020-03461-4","article-title":"Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1","volume":"147","author":"Gallitto","year":"2020","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0825","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1158\/1541-7786.MCR-11-0007","article-title":"MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression","volume":"9","author":"Wang","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0830","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.cell.2026.03.005","article-title":"Senescence in cancer: hallmarks, paradoxes, and therapeutic promise","volume":"189","author":"Hinterleitner","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb0835","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41419-025-07651-8","article-title":"Therapy-induced senescence of glioblastoma cells is determined by the p21CIP1-CDK1\/2 axis and does not require activation of DREAM","volume":"16","author":"Schwarzenbach","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189660_bb0840","article-title":"Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0845","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1541-7786.MCR-13-0268","article-title":"The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines","volume":"13","author":"Perrigue","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0850","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1007\/s13277-015-4439-2","article-title":"Irradiation induces glioblastoma cell senescence and senescence-associated secretory phenotype","volume":"37","author":"Jeon","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18040550","article-title":"The paradox of senescence in glioblastoma: SASP as an emerging cancer hallmark","volume":"18","author":"Tarumi","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189660_bb0860","first-page":"1063","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"P\u00e9rez-Gonz\u00e1lez","year":"2023","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189660_bb0865","first-page":"567","article-title":"Epithelial-to-mesenchymal transition as a central driver of tumor cell plasticity","volume":"7","author":"Jimenez-Casta\u00f1o","year":"2026","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2026.189660_bb0870","doi-asserted-by":"crossref","DOI":"10.3390\/biology11020313","article-title":"Adapt to persist: glioblastoma microenvironment and epigenetic regulation on cell plasticity","volume":"11","author":"Uribe","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0875","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1038\/onc.2014.334","article-title":"DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2","volume":"34","author":"Lopez-Bertoni","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2026.189660_bb0880","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/0008-5472.CAN-13-0109","article-title":"Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma","volume":"73","author":"Natsume","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0885","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/1878-0261.12174","article-title":"Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B","volume":"12","author":"Staberg","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0890","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/ijc.32649","article-title":"Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation","volume":"146","author":"Mallm","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb0895","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical toxicities of histone deacetylase inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbcan.2026.189660_bb0900","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13148-019-0675-4","article-title":"Epigenetics in cancer therapy and nanomedicine","volume":"11","author":"Roberti","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbcan.2026.189660_bb0905","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10555-025-10253-7","article-title":"Epigenetic drugs in cancer therapy","volume":"44","author":"Suraweera","year":"2025","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbcan.2026.189660_bb0910","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/1570159X20666220922150456","article-title":"Advances on epigenetic drugs for pediatric brain tumors","volume":"21","author":"Skouras","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0915","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3390\/cells12111464","article-title":"Epidrugs in the therapy of central nervous system disorders: a way to drive on?","volume":"12","author":"Gladkova","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2026.189660_bb0920","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fonc.2015.00148","article-title":"Future clinical trials in DIPG: bringing epigenetics to the clinic","volume":"5","author":"Morales La Madrid","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0925","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00448","article-title":"Epigenetic targeting of glioblastoma","volume":"8","author":"Romani","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0930","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4252\/wjsc.v13.i7.670","article-title":"Epigenetic modulators for brain cancer stem cells: implications for anticancer treatment","volume":"13","author":"Abballe","year":"2021","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.bbcan.2026.189660_bb0935","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-023-02923-7","article-title":"Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks","volume":"43","author":"Stitzlein","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0940","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11060-023-04445-w","article-title":"Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells","volume":"164","author":"Vollmer","year":"2023","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0945","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1158\/1078-0432.CCR-05-2849","article-title":"Valproic acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts","volume":"12","author":"Shu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189660_bb0950","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1158\/1535-7163.MCT-05-0184","article-title":"Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC","volume":"4","author":"Li","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2026.189660_bb0955","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2018.10.012","article-title":"Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma","volume":"442","author":"Choi","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2026.189660_bb0960","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00401-011-0866-3","article-title":"A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat","volume":"122","author":"Milde","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0965","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41419-020-2586-x","article-title":"Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma","volume":"11","author":"Auzmendi-Iriarte","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2026.189660_bb0970","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11060-011-0604-7","article-title":"Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures","volume":"105","author":"Xu","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb0975","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.18632\/oncotarget.1534","article-title":"BET bromodomain protein inhibition is a therapeutic option for medulloblastoma","volume":"4","author":"Henssen","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb0980","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb0985","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041877","article-title":"The BET inhibitor OTX015 exhibits in vitro and in vivo antitumor activity in pediatric Ependymoma stem cell models","volume":"22","author":"Servidei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189660_bb0990","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/neuonc\/noab115","article-title":"BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma","volume":"23","author":"Gusyatiner","year":"2021","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb0995","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.18632\/oncotarget.1412","article-title":"Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT inhibitor Decitabine","volume":"4","author":"Turcan","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb1000","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-018-03055-1","article-title":"Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial","volume":"141","author":"Sandberg","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2026.189660_bb1005","doi-asserted-by":"crossref","first-page":"68557","DOI":"10.18632\/oncotarget.19782","article-title":"The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells","volume":"8","author":"Miele","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb1010","article-title":"Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas","volume":"3","author":"Keane","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.bbcan.2026.189660_bb1015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2026.189660_bb1020","doi-asserted-by":"crossref","first-page":"36530","DOI":"10.18632\/oncotarget.26370","article-title":"Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma","volume":"9","author":"Rogers","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2026.189660_bb1025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbrc.2013.04.049","article-title":"Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism","volume":"435","author":"Yang","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189660_bb1030","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/neuonc\/noad018","article-title":"Lysine-specific histone demethylase 1A (KDM1A\/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma","volume":"25","author":"Alejo","year":"2023","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2026.189660_bb1035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-016-0296-6","article-title":"Suberoylanilide hydroxamic acid represses glioma stem-like cells","volume":"23","author":"Hsu","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbcan.2026.189660_bb1040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2016.02.011","article-title":"HDAC and PI3K antagonists cooperate to inhibit growth of MYC-driven medulloblastoma","volume":"29","author":"Pei","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2026.189660_bb1045","first-page":"93","article-title":"Enhanced efficacy of histone deacetylase inhibitor panobinostat combined with dual PI3K\/mTOR inhibitor BEZ235 against glioblastoma","volume":"81","author":"Meng","year":"2019","journal-title":"Nagoya J. Med. Sci."},{"key":"10.1016\/j.bbcan.2026.189660_bb1050","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/jnen\/nlx088","article-title":"LBH589 inhibits glioblastoma growth and angiogenesis through suppression of HIF-1\u03b1 expression","volume":"76","author":"Yao","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbcan.2026.189660_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100722","article-title":"Epigenetic mechanisms histone deacetylase\u2013dependent regulate the glioblastoma angiogenic matrisome and disrupt endothelial cell behavior in vitro","volume":"23","author":"Menezes","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbcan.2026.189660_bb1060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081897","article-title":"Histone deacetylase inhibitors impair glioblastoma cell motility and proliferation","volume":"14","author":"Rampazzo","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189660_bb1065","doi-asserted-by":"crossref","first-page":"23370","DOI":"10.1038\/s41598-021-02584-6","article-title":"The novel BET inhibitor UM-002 reduces glioblastoma cell proliferation and invasion","volume":"11","author":"Jermakowicz","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb1070","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.703733","article-title":"EZH2 mediates proliferation, migration, and invasion promoted by estradiol in human glioblastoma cells","volume":"13","author":"Del Moral-Morales","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2026.189660_bb1075","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1172\/JCI129049","article-title":"HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models","volume":"130","author":"Nguyen","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189660_bb1080","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41598-023-27375-z","article-title":"Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition","volume":"13","author":"Graziani","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2026.189660_bb1085","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1002\/ijc.23407","article-title":"The DNA demethylating agent 5-aza-2\u2032-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma","volume":"122","author":"Natsume","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189660_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2026.102600","article-title":"DNMT inhibitor-based epigenetic modulation during manufacturing enhances car T-cell function and persistence in pediatric brain tumors","volume":"28","author":"El Ghorayeb","year":"2026","journal-title":"Cytotherapy"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:49:19Z","timestamp":1785973759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":218,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26001320"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189660","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping epigenetic alterations across brain tumor hallmarks","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189660"}}